|
BET1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.471800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.996030E-01 |
| Normal-vs-Stage2 |
1.297770E-01 |
| Normal-vs-Stage3 |
2.365000E-01 |
| Normal-vs-Stage4 |
2.960300E-03 |
| Stage1-vs-Stage2 |
3.904000E-01 |
| Stage1-vs-Stage3 |
5.839400E-01 |
| Stage1-vs-Stage4 |
2.820500E-02 |
| Stage2-vs-Stage3 |
8.449600E-01 |
| Stage2-vs-Stage4 |
5.661400E-01 |
| Stage3-vs-Stage4 |
4.405400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.677600E-02 |
| Normal-vs-AfricanAmerican |
5.899200E-01 |
| Normal-vs-Asian |
8.914400E-01 |
| Caucasian-vs-AfricanAmerican |
2.617000E-01 |
| Caucasian-vs-Asian |
5.745600E-01 |
| AfricanAmerican-vs-Asian |
7.323800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.566100E-02 |
| Normal-vs-Female |
2.108400E-01 |
| Male-vs-Female |
2.744000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.529200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.600100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.918300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.364400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.535000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.161000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.734800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.723200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.874200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.892400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.951000E-01 |
| Normal-vs-Grade 2 |
8.102000E-02 |
| Normal-vs-Grade 3 |
1.738020E-01 |
| Normal-vs-Grade 4 |
3.124300E-02 |
| Grade 1-vs-Grade 2 |
1.877590E-01 |
| Grade 1-vs-Grade 3 |
5.108200E-01 |
| Grade 1-vs-Grade 4 |
9.709600E-02 |
| Grade 2-vs-Grade 3 |
4.676600E-01 |
| Grade 2-vs-Grade 4 |
6.538800E-01 |
| Grade 3-vs-Grade 4 |
2.178400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.559000E-01 |
| Normal-vs-ccB subtype |
1.523890E-02 |
| ccA subtype-vs-ccB subtype |
4.644300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.555600E-02 |
| Normal-vs-N1 |
2.958200E-01 |
| N0-vs-N1 |
9.529000E-01 |
|
|
